Back to Search
AARTI KAMAT, MD
MD
Pediatric Hematology & Oncology Physician
NPI: 1629598115IndividualAccepts Medicare
Specialties, Licenses & Credentials
Pediatrics Physician
Pediatrics
Code: 208000000X
4301113139(MI)
Pediatric Hematology & Oncology PhysicianPrimary
Pediatrics — Pediatric Hematology-Oncology
Code: 2080P0207X
77701(MN)
Education
WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE
Class of 2017
Research & Publications (20)
Novel therapeutics for patients with non-muscle-invasive bladder cancer.
PMID 19496717·Expert Rev Anticancer Ther·2009
6-review
Estimation of virological and immunological parameters in subjects from South India infected with human immunodeficiency virus type 1 clade C and correlation of findings with occurrence of neurological disease.
PMID 19031329·J Neurovirol·2009
8-other
EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer.
PMID 19396818·Cancer·2009
8-other
Anti-CTLA-4 therapy results in higher CD4+ICOShi T cell frequency and IFN-gamma levels in both nonmalignant and malignant prostate tissues.
PMID 19202079·Proc Natl Acad Sci U S A·2009
8-other
Squamous cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 16 cases.
PMID 19454359·Hum Pathol·2009
8-other
Dietary intake of vegetables and fruits and the modification effects of GSTM1 and NAT2 genotypes on bladder cancer risk.
PMID 19549811·Cancer Epidemiol Biomarkers Prev·2009
8-other
Outcome of patients with bladder cancer with pN+ disease after preoperative chemotherapy and radical cystectomy.
PMID 18848348·Urology·2009
8-other
Human immunodeficiency virus type 1 V1-to-V5 envelope variants from the chronic phase of infection use CCR5 and fuse more efficiently than those from early after infection.
PMID 19625411·J Virol·2009
8-other
Key concerns about the current state of bladder cancer: a position paper from the Bladder Cancer Think Tank, the Bladder Cancer Advocacy Network, and the Society of Urologic Oncology.
PMID 19536899·Cancer·2009
8-other
Retinopathy of prematurity in a tertiary care center--incidence, risk factors and outcome.
PMID 19179740·Indian Pediatr·2009
8-other
Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.
PMID 19156917·Cancer·2009
8-other
Long-term outcome for men with teratoma found at postchemotherapy retroperitoneal lymph node dissection.
PMID 19156903·Cancer·2009
4-observational
Erythropoeisis-stimulating agents (ESAs) in cervix cancer: The "black box" paradox.
PMID 19127119·Cancer Biol Ther·2009
8-other
Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer.
PMID 19414678·J Clin Oncol·2009
3-trial
Definition and management of patients with bladder cancer who fail BCG therapy.
PMID 19496718·Expert Rev Anticancer Ther·2009
6-review
Functional significance of VEGFR-2 on ovarian cancer cells.
PMID 19058181·Int J Cancer·2009
7-preclinical
Estrogen receptor alpha (ERalpha) mediates stimulatory effects of estrogen on aromatase (CYP19) gene expression in human placenta.
PMID 19299445·Mol Endocrinol·2009
8-other
Dicer, Drosha, and outcomes in patients with ovarian cancer.
PMID 19092150·N Engl J Med·2008
4-observational
1,1-Bis(3'-indolyl)-1-(p-chlorophenyl)methane activates the orphan nuclear receptor Nurr1 and inhibits bladder cancer growth.
PMID 19074857·Mol Cancer Ther·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 1500 E MEDICAL CENTER DR
ANN ARBOR, MI 48109 - Phone
- (734) 647-2893
Quick Facts
- NPI
- 1629598115
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 3
- Years in Practice
- 9
- Publications
- 20
Are you this provider?
Claim Your Profile